ArticleJournal of cardiothoracic surgery2025
The role of the modified Glasgow prognostic score in predicting postoperative mortality following open-heart surgery.
Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe Modified Glasgow Prognostic Score is an inflammation-based index utilizing C-reactive protein and albumin levels. It has been investigated in various diseases such as cancer, heart failure, and myocardial infarction. Open heart surgery, particularly with cardiopulmonary bypass, induces an acute-phase inflammatory response that is associated with postoperative complications and mortality. This study aimed to evaluate the prognostic value of preoperative and early postoperative Modified Glasgow Prognostic Score in predicting early outcomes in patients undergoing open heart surgery, with the goal of improving patient stratification and surgical decision-making.
methodsA retrospective review of medical records was conducted for 456 patients who underwent open heart surgery between January 1, 2022, and October 1, 2024. All procedures were elective cases. Patients undergoing emergency operations, including those with acute type A aortic dissection, were excluded from the study. Data were collected on demographics, laboratory results, procedure duration, ejection fraction, and presence of multi-vessel disease. All patients included in the study underwent open heart surgery with the use of cardiopulmonary bypass (CPB). Patients who underwent off-pump coronary artery bypass grafting (OPCAB) or other procedures not requiring CPB were excluded. Both preoperative and postoperative Modified Glasgow Prognostic Score were analyzed to assess their association with early postoperative outcomes.
resultsPreoperative mGPS was found to be significantly associated with early mortality (p < 0.05). A one-unit increase in Modified Glasgow Prognostic Score was associated with a 2.85-fold increase in mortality risk (95% CI: 1.85–4.41). However, no significant relationship was observed between postoperative Modified Glasgow Prognostic Score and mortality (p > 0.05).
conclusionsPreoperative Modified Glasgow Prognostic Score serves as a valuable prognostic marker for early mortality in open heart surgery patients. It provides independent predictive value and can enhance preoperative risk assessment, ultimately improving patient outcomes and guiding surgical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.